Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.98 CAD | -7.45% | +1.71% | +170.91% |
May. 14 | Cardiol Therapeutics Says Phase II ARCHER Trial Presented at World Congress on Acute Heart Failure | MT |
Apr. 22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |